Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...